The study confirms the genetic homogeneity of CACP syndrome despite its clinical variability, emphasizing hip and spine involvement.
Answers are grounded in this paper and cite their sources.
Clinical variability warrants CACP consideration for targeted testing; leaves open full genotype-phenotype mapping.
The camptodactyly-arthropathy-coxa vara-pericarditis syndrome (CACP) is an autosomal recessive condition characterized by the association of congenital or early onset camptodactyly and noninflammatory arthropathy with synovial hyperplasia. Progressive coxa vara deformity and/or noninflammatory pericardial or pleural effusions have been observed in some patients. Recently, the disease gene has been assigned to human chromosome region 1q25-q31, and truncating mutations have been identified in the megakaryocyte stimulating factor gene. Studying 12 patients from 8 unrelated families, we emphasized hip and spine involvement, particularly in the course of the disease as shown in a 58-year-old patient. Despite clinical variability, linkage studies support genetic homogeneity of the disease.
No takes yet. Share an insight, caveat, or question.
Faivre et al. (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: